• News
  • SAN DIEGO
  • Finance

BioMed reports increased revenue in 3Q

San Diego real estate investment trust BioMed Realty Trust Inc. (NYSE: BMR) announced Friday its financial results for the third quarter ended Sept. 30, with news that the company increased funds from operations for the quarter by 13.3 percent to $0.34 per diluted share, as compared to $0.30 per diluted share in the third quarter of 2011.

BioMed also increased adjusted funds from operations for the quarter by 10 percent to $0.33 per diluted share, as compared to $0.30 per diluted share in the third quarter of 2011. The company's total operating portfolio leased percentage rose to approximately 90.5 percent at quarter end, on a weighted-average basis, as the result of executing 22 leasing transactions during the quarter representing approximately 367,400 square feet.

Total revenues for the third quarter were $134.5 million, compared to $114.6 million for the same period in 2011. Rental revenues for the third quarter were $101.5 million, compared to $83.5 million for the same period in 2011. The company reported net income available to common stockholders for the third quarter of $2.8 million, or $0.02 per diluted share.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

BioMed Realty Trust Inc.

Company Website

17190 Bernardo Center Dr.
San Diego, CA 92128

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
BMR
23.4
  0.04  
+ 0.17%
6,342,798,000
25.11
17.94

Insider Trade Data

Date Insider Shares Type Value
08/17/2015 Bonanno, John P 4,800 Sell $100,848
08/17/2015 Bonanno, John P 4,800 Sell $100,848
07/31/2015 Gold, Alan D 50,000 Sell $1,076,500
07/31/2015 Gold, Alan D 50,000 Sell $1,076,500
06/15/2015 Berens, James R 2,000 Sell $39,990

BioMed Realty Trust Inc. Executive(s):

Alan Gold

  • Chairman, Chief Executive Officer, President

Related Videos

Interview with Alan Gold of Biomed Realty Trust

Sept. 28, 2011 -- Executive Editor George Chamberlin talks with Alan Gold, president and CEO of Biomed Realty Trust, about the types of properties and projects Biomed Realty takes on.

Similar Companies

NAICS - 531120 - Lessors of Nonresidential Buildings (except Miniwarehouses)